Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for EPC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 118.70M
March 31, 2026 54.30M
December 31, 2025 -125.90M
September 30, 2025 74.10M
June 30, 2025 114.80M
March 31, 2025 45.10M
December 31, 2024 -115.60M
September 30, 2024 73.70M
June 30, 2024 101.20M
March 31, 2024 129.00M
December 31, 2023 -72.90M
September 30, 2023 47.80M
June 30, 2023 166.40M
March 31, 2023 88.20M
December 31, 2022 -86.30M
September 30, 2022 29.60M
June 30, 2022 112.30M
March 31, 2022 39.10M
December 31, 2021 -79.00M
September 30, 2021 73.10M
June 30, 2021 174.70M
March 31, 2021 63.70M
December 31, 2020 -82.50M
September 30, 2020 114.00M
June 30, 2020 101.40M
Date Value
March 31, 2020 64.10M
December 31, 2019 -46.90M
September 30, 2019 92.40M
June 30, 2019 130.10M
March 31, 2019 14.50M
December 31, 2018 -46.40M
September 30, 2018 77.90M
June 30, 2018 119.90M
March 31, 2018 82.60M
December 31, 2017 -21.00M
September 30, 2017 194.20M
June 30, 2017 119.80M
March 31, 2017 58.60M
December 31, 2016 -59.00M
September 30, 2016 172.30M
June 30, 2016 76.70M
March 31, 2016 -13.90M
December 31, 2015 -58.70M
September 30, 2015 125.10M
June 30, 2015 -56.10M
March 31, 2015 111.80M
December 31, 2014 -32.00M
September 30, 2014 193.30M
June 30, 2014 149.80M
March 31, 2014 177.80M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Coty, Inc. 116.00M
The Estée Lauder Companies, Inc. 576.00M
Interparfums, Inc. 45.58M
United-Guardian, Inc. 1.52M
BioForce Nanosciences Holdings, Inc. -0.027M